Transformation of an ameloblastic fibroma to an ameloblastic fibrosarcoma has been reported rarely in the literature. The present case report describes such evolution in a patient under long-term follow-up. The patient was first treated in 2008, and he developed the malignant counterpart of the disease 2 years later. The patient is currently under careful long-term follow-up and is free of disease. This article describes the clinical and radiographic features, histological characteristics, immunohistochemical findings, and surgical treatment of the tumor.
NoordhoekRPizerMELaskinDM. Ameloblastic fibrosarcoma of the mandible: treatment, long-term follow-up, and subsequent reconstruction of a case. J Oral Maxillofac Surg. 2012;70:2930-2935.
2.
LaiJBlanasNHigginsKKliebH. Ameloblastic fibrosarcoma: report of a case, study of immunophenotype, and comprehensive review of the literature. J Oral Maxillofac Surg. 2012;70:2007-2012.
3.
WilliamsMDHannaEYEl-NaggarAK. Anaplastic ameloblastic fibrosarcoma arising from recurrent ameloblastic fibroma: restricted molecular abnormalities of certain genes to the malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:72-75.
4.
KobayashiKMurakamiRFujiiTHiranoA. Malignant transformation of ameloblastic fibroma to ameloblastic fibrosarcoma: case report and review of the literature. J Craniomaxillofac Surg. 2005;33:352-355.
5.
Al ShetawiHAlpertEHBuchbinderDUrkenML. Ameloblastic fibrosarcoma of the mandible: a case report and a review of the literature. J Oral Maxillofac Surg. 2015;73:1661.e1-e7.
6.
Loya-SolisAGonzález-ColungaKJPérez-RodríguezCMRamírez-OchoaNSCeceñas-FalcónLBarboza-QuintanaO. Ameloblastic fibrosarcoma of the mandible: a case report and brief review of the literature. Case Rep Pathol. 2015;2015:245026.
7.
BatistadePaulaAMda Costa NetoJQda Silva GusmãoEGuimarães SantosFBGomezRS. Immunolocalization of the p53 protein in a case of ameloblastic fibrosarcoma. J Oral Maxillofac Surg. 2003;61:256-258.
8.
PontesHAPontesFSSilvaBSImmunoexpression of Ki67, proliferative cell nuclear antigen, and Bcl-2 proteins in a case of ameloblastic fibrosarcoma. Ann Diagn Pathol. 2010;14:447-452.
9.
GalvãoCFGomesCCDinizMGLoss of heterozygosity (LOH) in tumour suppressor genes in benign and malignant mixed odontogenic tumours. J Oral Pathol Med. 2012;41:389-393.
10.
Nogueira TdeOCarvalhoYRRosaLEDos SantosLM. Possible malignant transformation of an ameloblastic fibroma to ameloblastic fibrosarcoma: a case report. J Oral Maxillofac Surg. 1997;55:180-182.
